Arterial thromboembolism in patients with cancer and atrial fibrillation
Atrial fibrillation (AF) is common in patients with cancer, and up to one in every four persons with AF has comorbid...
Trials and Therapy
The prevalence of potential drug–drug interactions in cancer patients treated with anticoagulants
During the ICTHIC webinar, “Long-term treatment & DDI implications in the management of CAT,” Dr. Tzu-Fei Wang...
Management of the incidents of VTE in cancer patients
During the ICTHIC webinar, “Updates in cancer-associated thrombosis,” Dr. Luis Jara-Palomares gave a lecture on the...
Management of VTE beyond 12 months in patients with cancer-associated thrombosis
During the ICTHIC webinar, “Long-term treatment & DDI implications in the management of CAT,” Dr. Luis...
Prediction of disease progression and mortality in patients with metastatic gastrointestinal cancer: the role of thrombin generation and D-dimer
Gastrointestinal (GI) cancers represent 26% of the global cancer incidence and more than one-third of all...
Low-dose apixaban as secondary prophylaxis in patients with cancer: is it safe?
Recurrent venous thromboembolism (VTE) and major bleeding are the two major challenges in managing cancer-associated...
Insights from TESEO, cancer-associated thrombosis registry from the Spanish Society of Medical Oncology (SEOM) – Highlights from the webinar
During the ICTHIC webinar “Clinical insights in CAT to include COVID‐19“, prof Andrez Muñoz shared data...
The TESEO registry and how it can help patients with CAT
Cancer-associated thrombosis management is incredibly challenging because of the high risk of recurrence and severe...
Inpatient thromboprophylaxis in cancer patients: what is the evidence? A talk report from the 10th ICTHIC
During the 10th ICTHIC, Prof. Jeffrey Zwicker (Harvard Medical School, MA, USA) gave an overview of the evidence of the...
Awareness of venous thromboembolism risk in cancer patients: the oncologist knowledge gap
The management of cancer-associated venous thrombosis (CAT) is particularly challenging because of a high risk of major...